Literature DB >> 12381634

Increased plasma concentrations of interleukin-18 in acute coronary syndromes.

Z Mallat1, P Henry, R Fressonnet, S Alouani, A Scoazec, P Beaufils, Y Chvatchko, A Tedgui.   

Abstract

OBJECTIVE: To examine the relation between plasma concentrations of interleukin-18 (IL-18), the interferon gamma inducing factor, and clinical instability of coronary artery disease. DESIGN AND
SETTING: Observational study in a university hospital. PATIENTS: 11 patients with unstable angina and negative troponin I, 21 patients with acute non-Q wave myocardial infarction (MI), 21 patients with acute Q wave MI, 9 patients with stable angina, and 11 controls. MAIN OUTCOME MEASURES: Plasma IL-18 concentrations and their relation to clinical instability and myocardial dysfunction.
RESULTS: Plasma concentrations of IL-18 were significantly increased in the unstable angina and MI groups in comparison with the stable angina and control groups (p < 0.01). No difference in IL-18 concentrations were found between patients with unstable angina, patients with non-Q wave MI, and patients with Q wave MI. Plasma IL-18 concentrations significantly correlated with decreased left ventricular ejection fraction (p = 0.01).
CONCLUSIONS: Plasma IL-18 concentrations are increased in patients with acute coronary syndromes and correlate with the severity of myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381634      PMCID: PMC1767431          DOI: 10.1136/heart.88.5.467

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

1.  Interleukin 18 in acute myocardial infarction.

Authors:  Y Seta; T Kanda; T Tanaka; M Arai; K Sekiguchi; T Yokoyama; M Kurimoto; J Tamura; M Kurabayashi
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

2.  Interleukin-18 acts as an angiogenesis and tumor suppressor.

Authors:  R Cao; J Farnebo; M Kurimoto; Y Cao
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

Review 3.  Interleukin-18, a proinflammatory cytokine.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

4.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.

Authors:  B J Pomerantz; L L Reznikov; A H Harken; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.

Authors:  I Jeremias; C Kupatt; A Martin-Villalba; H Habazettl; J Schenkel; P Boekstegers; K M Debatin
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

6.  Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability.

Authors:  Z Mallat; A Corbaz; A Scoazec; P Graber; S Alouani; B Esposito; Y Humbert; Y Chvatchko; A Tedgui
Journal:  Circ Res       Date:  2001-09-28       Impact factor: 17.367

7.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 8.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability.

Authors:  Z Mallat; A Corbaz; A Scoazec; S Besnard; G Lesèche; Y Chvatchko; A Tedgui
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

10.  Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.

Authors:  H Tsutsui; N Kayagaki; K Kuida; H Nakano; N Hayashi; K Takeda; K Matsui; S Kashiwamura; T Hada; S Akira; H Yagita; H Okamura; K Nakanishi
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

View more
  32 in total

1.  Protein Cytokines, Cytokine Gene Polymorphisms, and Potential Acute Coronary Syndrome Symptoms.

Authors:  Sahereh Mirzaei; Larisa Burke; Anne G Rosenfeld; Susan Dunn; Jennifer R Dungan; Katherine Maki; Holli A DeVon
Journal:  Biol Res Nurs       Date:  2019-06-25       Impact factor: 2.522

Review 2.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.

Authors:  Frederik H Verbrugge; Matthias Dupont; Zhili Shao; Kevin Shrestha; Dhssraj Singh; Michael Finucan; Wilfried Mullens; W H Wilson Tang
Journal:  J Card Fail       Date:  2013-09       Impact factor: 5.712

Review 4.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 5.  The role of the inflammasome in cardiovascular diseases.

Authors:  Xuan Li; Nicolas Deroide; Ziad Mallat
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

6.  Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction.

Authors:  Hee Tae Yu; Jong-Chan Youn; Jino Lee; Seunghyun Park; Ho-Seok Chi; Jungsul Lee; Chulhee Choi; Sungha Park; Donghoon Choi; Jong-Won Ha; Eui-Cheol Shin
Journal:  Cell Mol Immunol       Date:  2014-08-25       Impact factor: 11.530

Review 7.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 8.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

9.  Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide.

Authors:  Gipsy Majumdar; I Maria Johnson; Santosh Kale; Rajendra Raghow
Journal:  Mol Cell Biochem       Date:  2008-02-22       Impact factor: 3.396

10.  Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.

Authors:  Catherine Desrumaux; Stéphanie Lemaire-Ewing; Nicolas Ogier; Akadiri Yessoufou; Arlette Hammann; Anabelle Sequeira-Le Grand; Valérie Deckert; Jean-Paul Pais de Barros; Naïg Le Guern; Julien Guy; Naim A Khan; Laurent Lagrost
Journal:  Cell Mol Immunol       Date:  2015-08-31       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.